Shanghai North Carolina's wholly-owned acquisition of Anhui Zhongwang Jianfeng Pharmaceutical API Base is beginning to take shape.
Release time:
2020-07-31
News from our newspaper 8# April 3 , Shanghai Beika Pharmaceutical Technology Co., Ltd., a subsidiary of Jianfeng Pharmaceutical Co., Ltd., signed an equity transfer agreement with shareholders of Anhui Zhongwang Pharmaceutical Co., Ltd. to invest ,2062 yuan to acquire all 100% shares of the company. This is another important move to build a production base for API after the acquisition of equity in Shanghai North Carolina at the beginning of the year.
Anhui Zhongwang is located in Xiangyu Chemical Park, Dongzhi County, Chizhou City, Anhui Province. It is a pharmaceutical intermediate manufacturing enterprise integrating R & D, production and sales, focusing on characteristic medicine, intermediates, new materials, etc. R & D, production and sales of fine chemicals. The main business activities are the production and sales of 92% potassium hydrogen fluoride and 8% potassium fluoride mixture, ethyl acetate, aqueous DMF , aqueous triethylamine, toluene, methanol, acetic acid, DMF , triethylamine, industrial sodium chloride, chemical products (except hazardous chemicals and explosives); Research and development of biopharmaceuticals, chemical raw materials, pharmaceutical intermediates and fine chemicals. The company has two ofloxacin carboxylic acid production lines with a total production capacity of 1200 tons / years, and its supporting safety, environmental protection, storage and management systems, and has passed ISO9001 : 2015 quality management system certification, ISO14001 : 2015 environmental management system certification, OHSAS18001 : 2015 occupational health and safety management system certification and safety three-level standardization construction; the main products, oxyfluorocarboxylate, oxyfluorocarboxylate, levooxyfluorocarboxylate and levooxyfluorocarboxylate, passed the on-site audit of well-known domestic pharmaceutical enterprises, levofluorocarboxylate passed the on-site audit of Indian pharmaceutical enterprises, and received the on-site audit of oxyfluorocarboxylate process verification from U.S. pharmaceutical enterprises in 2017 , and was expected to be registered in U.S. document DMF as a supplier of oxyfluorocarboxylate starting materials. The equity acquisition of Anhui Zhongwang is an important measure to strengthen the development of the pharmaceutical business sector according to the company's strategic policy of "strengthening the main business through cooperation and innovation, standardizing science and seeking development. After the acquisition, Anhui Zhongwang will become a wholly-owned subsidiary of Shanghai Beika. The company plans to use the factory building and construction land of Anhui Zhongwang to plan the construction of pharmaceutical intermediates and API projects, which is conducive to the overall layout of Jianfeng Pharmaceutical's chemical API base in Anhui: the pesticide and primary pharmaceutical intermediates will be arranged in the factory area of Anhui Xinbeika Chemical Co., Ltd., and the API and advanced pharmaceutical intermediates will be arranged in the factory area of Anhui Zhongwang, it can make full use of Anhui Zhongwang's factory area, public engineering facilities, quality management system and other advantages to speed up the construction progress of Jianfeng Pharmaceutical Anhui Chemical Raw Material Drug Base. In addition, the acquisition of Anhui Zhongwang will also help expand the R & D, production and sales of Shanghai North Carolina's existing fine chemicals business such as intermediates and new materials, further extend and improve the industrial chain, and consolidate its market position. (this newspaper reporter)
More information
Peak re-listed China's top 100 cement production capacity Daye peak won the "smart factory leader"
On July 11-12, the 2022 China Cement Industry Summit and TOP100 Award Ceremony organized by China Cement Network, an authoritative media of China's cement industry, was held in Hangzhou. Jianfeng Group once again ranked among the top 100 cement clinker production capacity in China.
2022
08-04
On the afternoon of July 12, the party Committee of the group company held a special meeting attended by party Committee members, senior and middle-level management backbones, heads of grass-roots party organizations and all party members of the group headquarters to learn and convey the spirit of the 15th party congress of the communist party of China in Zhejiang province.
2022
07-24
On the morning of July 1, more than 40 members of the group's party committee, party members of various branches of the group headquarters, and party members of subordinate enterprise branches went to the Shuanglong Hydropower Station, the Red Education Base of Jinhua City, to receive party spirit and revolutionary tradition education.
2022
07-14
Vocational skill level identification examination!
On June 16 and 18, the theoretical and practical examinations for the determination of professional skill level in the peak pharmaceutical sector were held successively in Jinxi pharmaceutical factory. The independent identification of vocational skill level includes three occupations (types of work): pharmaceutical preparation worker, chemical inspector and organic synthesis worker, basically covering the main posts in the pharmaceutical sector, with a total of 125 employees signing up for the identification.
2022
06-21
On June 16, the Jianfeng Pharmaceutical Quality Research and Development Party Branch and the Jinhua Vocational Skills Management Service Center Party Branch held a signing ceremony in Jinxi Factory to establish a party building alliance.
2022
06-21
Jinhua Mayor Xing Zhihong to Peak Research
On the afternoon of June 1, Jinhua Mayor Xing Zhihong, Wucheng District Party Committee Secretary Gao Feng, District Mayor Hu Yuxian, and heads of the Municipal Economic and Information Bureau, Development and Reform Bureau and other departments went to the group headquarters to discuss and exchange with the leaders of the group company to understand the development of the enterprise. Solicit opinions and suggestions from enterprises on government work. After understanding the current business situation of the peak, Xing Zhihong pointed out that focus, follow the right path, frontier, steady, is the peak to long-term prosperity of the magic weapon, must continue to adhere.
2022
06-13